ReviewAnnals of biomedical engineering2026
Functional Bioink and 3D Bioprinting Tissue Scaffold Applications for Spinal Cord Injury.
Review in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord injury (SCI), commonly resulting from sudden trauma such as traffic or sports accidents, leads to severe disruption of axonal connections and loss of sensory and motor function below the injury site. Despite numerous therapeutic efforts, effective strategies for neural repair remain limited. Tissue engineering has emerged as a promising approach for axonal regeneration, particularly through the design of three-dimensional (3D) polymeric scaffolds that can restore the structural and functional integrity of the injured spinal cord. This review focuses on recent advances in biomaterials and scaffold designs developed for SCI repair, emphasizing the role of nanocomposite systems that combine graphene oxide (GO), synthetic polymers such as PLGA-PEG, and bioactive ceramics like hydroxyapatite (HA). These hybrid materials offer improved biocompatibility, mechanical matching with spinal tissue, and enhanced cellular adhesion and guidance cues for axonal growth. The synergistic integration of these components enables the fabrication of multifunctional scaffolds capable of supporting stem cell differentiation and neurotrophic factor delivery. By critically summarizing the key parameters influencing scaffold performance, such as microarchitecture, surface modification, and mechanical compliance, this work outlines a framework for developing next-generation 3D nanocomposite scaffolds for SCI regeneration. The proposed approach highlights how GO/PLGA-PEG/HA systems can bridge the gap between experimental tissue engineering and clinically translatable neuroregenerative therapies.
Indexed as
Identifiers
41239033What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.